| Primary |
| Psychotic Disorder |
15.5% |
| Schizophrenia |
11.9% |
| Bipolar Disorder |
8.3% |
| Hypothyroidism |
7.1% |
| Vitamin Supplementation |
7.1% |
| Gastrooesophageal Reflux Disease |
6.0% |
| Prostatic Disorder |
6.0% |
| Bipolar I Disorder |
4.8% |
| Depression |
4.8% |
| Hypertension |
4.8% |
| Ill-defined Disorder |
4.8% |
| Schizoaffective Disorder |
4.8% |
| Anxiety |
2.4% |
| Diabetes Mellitus |
2.4% |
| Hallucination |
2.4% |
| Tourette's Disorder |
2.4% |
| Agitation |
1.2% |
| Dementia Alzheimer's Type |
1.2% |
| Electrolyte Imbalance |
1.2% |
| Erectile Dysfunction |
1.2% |
|
| Weight Increased |
15.6% |
| Tardive Dyskinesia |
9.4% |
| Thinking Abnormal |
9.4% |
| Drug Dose Omission |
6.3% |
| Pain |
6.3% |
| Psychomotor Hyperactivity |
6.3% |
| Tachyphrenia |
6.3% |
| Asthenia |
3.1% |
| Cardiac Arrest |
3.1% |
| Chromaturia |
3.1% |
| Condition Aggravated |
3.1% |
| Cough |
3.1% |
| Disease Recurrence |
3.1% |
| Disturbance In Attention |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Drug Ineffective |
3.1% |
| Drug Screen Positive |
3.1% |
| Extrapyramidal Disorder |
3.1% |
| Fatigue |
3.1% |
| Feeling Jittery |
3.1% |
|
| Secondary |
| Bipolar Disorder |
14.3% |
| Schizophrenia |
12.9% |
| Depression |
10.0% |
| Psychotic Disorder |
8.6% |
| Schizoaffective Disorder |
8.6% |
| Hypertension |
7.1% |
| Mental Disorder |
5.0% |
| Hallucination |
3.6% |
| Sleep Disorder |
3.6% |
| Diabetes Mellitus |
2.9% |
| Headache |
2.9% |
| Nervousness |
2.9% |
| Smoking Cessation Therapy |
2.9% |
| Tourette's Disorder |
2.9% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hypothyroidism |
2.1% |
| Post-traumatic Stress Disorder |
2.1% |
| Prostatic Disorder |
2.1% |
| Vitamin Supplementation |
2.1% |
| Anxiety |
1.4% |
|
| Weight Increased |
13.5% |
| Psychomotor Hyperactivity |
10.8% |
| Therapeutic Response Unexpected |
10.8% |
| Schizoaffective Disorder |
8.1% |
| Bipolar Disorder |
5.4% |
| Drug Hypersensitivity |
5.4% |
| Tardive Dyskinesia |
5.4% |
| Tremor |
5.4% |
| Weight Decreased |
5.4% |
| Anxiety |
2.7% |
| Blood Glucose Increased |
2.7% |
| Blood Pressure Decreased |
2.7% |
| Chromaturia |
2.7% |
| Cough |
2.7% |
| Drug Dose Omission |
2.7% |
| Extrapyramidal Disorder |
2.7% |
| Fatigue |
2.7% |
| Feeling Abnormal |
2.7% |
| Generalised Erythema |
2.7% |
| Haematuria |
2.7% |
|
| Concomitant |
| Depression |
19.5% |
| Schizophrenia |
17.0% |
| Bipolar Disorder |
16.2% |
| Anxiety |
9.1% |
| Sleep Disorder |
4.5% |
| Psychotic Disorder |
3.5% |
| Insomnia |
3.2% |
| Agitation |
3.0% |
| Schizoaffective Disorder |
3.0% |
| Mental Disorder |
2.8% |
| Pain |
2.8% |
| Hypertension |
2.4% |
| Smoking Cessation Therapy |
2.0% |
| Drug Use For Unknown Indication |
1.8% |
| Migraine |
1.8% |
| Schizophrenia, Paranoid Type |
1.6% |
| Affective Disorder |
1.5% |
| Paranoia |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Diabetes Mellitus |
1.2% |
|
| Type 2 Diabetes Mellitus |
37.1% |
| Weight Increased |
11.9% |
| Tardive Dyskinesia |
10.0% |
| Pancreatitis |
8.2% |
| Type 1 Diabetes Mellitus |
5.6% |
| Diabetic Coma |
3.0% |
| Weight Decreased |
3.0% |
| Diabetes Mellitus |
2.8% |
| Obesity |
2.6% |
| Thyroid Neoplasm |
2.3% |
| Diabetic Ketoacidosis |
2.1% |
| Hypertension |
2.1% |
| Overdose |
1.4% |
| Vomiting |
1.4% |
| Granulocytopenia |
1.2% |
| Neuropathy Peripheral |
1.2% |
| Pain |
1.2% |
| Vision Blurred |
1.2% |
| Blood Triglycerides Increased |
0.9% |
| Diabetic Retinopathy |
0.9% |
|
| Interacting |
| Emotional Disorder |
40.0% |
| Mental Disorder |
40.0% |
| Smoking Cessation Therapy |
10.0% |
| Tobacco User |
6.7% |
| Bipolar Disorder |
3.3% |
|
| Weight Decreased |
80.0% |
| Tension |
20.0% |
|
